Personality, quality of life and HAART adherence among men and women living with HIV/AIDS

Journal of Psychosomatic Research

Volumn 54, Issue 3, 2003, Pages 271-278

  Penedo, Frank J ^a   Gonzalez, Jeffrey S ^a   Dahn, Jason R ^a   Antoni, Mike ^a,b   Malow, Robert ^b   Costa, Paul ^c   Schneiderman, Neil ^a,b  

^a Department of Biology   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c NATIONAL INSTITUTE ON AGING   (United States)

Author keywords

AIDS; HAART adherence; HIV; Personality; Quality of life

Indexed keywords

ANTIRETROVIRUS AGENT; NUCLEOSIDE ANALOG; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CORRELATION ANALYSIS; DISEASE ASSOCIATION; EXTRAVERSION; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERPERSONAL COMMUNICATION; LIFE SATISFACTION; MAJOR CLINICAL STUDY; MALE; NEUROSIS; PATIENT COMPLIANCE; PERSONALITY; PSYCHOSOCIAL CARE; QUALITY OF LIFE; SEXUAL FUNCTION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; FEMALE; HEALTH STATUS; HUMANS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PERSONALITY; QUALITY OF LIFE;

EID: 0037350958     PISSN: 00223999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0022-3999(02)00482-8     Document Type: Article

References (40)

1. Ball SA, Schottenfeld RS. A five-factor model of personality and addiction, psychiatric, and AIDS risk severity in pregnant and post-partum cocaine misusers. Subst Use Misuse 1997;32(1):25-41.
2. 3. Paper presented at the XI International Conference on AIDS, Vancouver, British Columbia, Canada, 1996. 1996.
3. Burgess AP, Carretero M, Elkington A, Pasqual-Marsettin E, Lobaccaro C, Catalan J. The role of personality, coping style and social support in health-related quality of life in HIV infection. Qual Life Res 2000;9:423-37.
4. Cameron W, Heath-Choizzi M, Kravcik S. Prolongation of life and prevention of AIDS in advanced HIV immunodeficiency with ritonavir. Paper presented at the Paper presented at the Third Conference on Retroviruses and Opportunistic Infections, Washington, DC, 1996.
5. Centers for Disease Control, CDC. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. Morb Mort Wkly Rep 1992;41:1-19.
6. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, Wu AW. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG Adherence Instruments. AIDS Care 2000;12(3):255-66.
7. Chesney M, Folkman S. Psychological impact of HIV disease and implications for intervention. Psychiatr Clin North Am 1994;17(1):163-82.
8. Collier AC, Coombs RW, Schoenfeld DA, Basset RL, Timpone J, Baruch A, Jones M, Facey K, Whitacre C, McAuliffe VJ, Friedman HM, Flerigan TC, Reichman RC, Hooper C, Carey L. Treatment of human immunodeficiency virus infection with sasquinavir, zidovudine, and zalcitabine. N Engl J Med 1996;334:1011-1017.
9. Costa PT, McCrae RR, Dye DA. Facet scales for agreeableness and conscientiousness: A revision of the NEO personality inventory. Pers Individ Differ 1991;12:887-98.
10. Costa PT, McCrae RR. Revised NEO personality inventory: Professional manual. Odessa (FL): Psychological Assessment Resources, 1992.
11. Deeks S, Smith M, Holodniy M, Kahn J. HIV-1 protease inhibitors: A review for clinicians. J Am Med Assoc 1997;2:145-53.
12. Fahey JL, Taylor JM, Detels R, Hofman B, Melmed R, Nishanian P, Giorgi J. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type-1. N Engl J Med 1990;322:166-72.
13. First MB, Spitzer RL, Gibbon M, Williams, Janet BW. The structured clinical interview for DSM-III-R personality disorders (SCID-II): I. Description. J Pers Disord 1995;9:83-91.
14. Fletcher MA, Baron G, Ashman M, Fischl M, Klimas N. Use of whole blood methods in assessment of immune parameters in immunodeficiency states. Diagn Clin Immunol 1987;5:69-81.
15. Folstein MF, Folstein SE, McHugh PR. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatry Res 1975;12:189-98.
16. Gallo RC. HIV-the cause of AIDS: An overview on its biology, mechanisms of disease induction, and out attempts to control it. J Acquir Immunodeficiency Syndr 1988;1:521-35.
17. Gallo RC. Virus Hunting AIDS, Cancer, and the Human Retrovirus: A Story of Scientific Discovery. New York: Basic Books, 1991.
18. Gupchup GV, Hubbard JH, Teel MA, Singhal PK, Tonrey L, Riley K, Rupp MT, Coultas DB. Developing a community specific health-related quality of life (HRQOL) questionnaire for asthma: The Asthma-Specific Quality of Life Questionnaire for Native American Adults (AQLQ-NAA). J Asthma 2001;38(2):169-78.
19. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry 1960;12:56-62.
20. Holmes WC. HAT-QoL: HIV/AIDS-Targeted Quality of Life Instrument, 1999.
21. Holmes WC, Shea JA. Two approaches to measuring quality of life in the HIV/AIDS population: HAT-QoL and MOS-HIV. Qual Life Res 1999;8:515-27.
22. Holzemer WL, Corless IB, Nokes KM, Turner JG, Brown MA, Powell-Cope GM, Inouye J, Henry SB, Nicholas PK, Portillo CJ. Predictors of self-reported adherence in persons living with HIV disease. AIDS Patient Care STDs 1999;13(3):185-97.
23. Johnson JG, Williams JBW, Rabkin JG, Goetz RR, Remien RH. Axis I psychiatric symptoms associated with HIV infection and personality disorder. Am J Psychiatry 1995;152(4):551-4.
24. Kemppainen J. Predictors of quality of life in AIDS patients. J Assoc Nurses AIDS Care 2001;12(1):61-70.
25. Linsk NL. HIV among older adults: Age-specific issues in prevention and treatment. AIDS Read 2000;10(7):430-40.
26. Lewin D. Protease inhibitors: HIV-1 summons a Darwinian defense. J NIH Res 1996;8:33-5.
27. Magnus K, Diener E, Fujita F, Payot W. Extraversion and neuroticism as predictors of objective life events: A longitudinal analysis. J Pers Soc Psychol 1993;65(5):1046-53.
28. McCrae RR, Costa PT. Discriminant validity of the NEO PI-R facet scales. Educ Psychol Meas 1992;52:229-37.
29. Miners AH, Sabin CA, Mocroft A, Youle M, Fisher M, Johnson M. Health-related quality of life in individuals infected with HIV in the era of HAART. HIV Clin Trials 2001;2(6):484-92.
30. Nieuwkerk P, Gisolf E, Reijers M, Lange J, Danner S, Sprangers M, NATIVE Study Group, PROMETHEUS Study Group, ADAM Study Group. Long-term quality of life outcomes in three antiretroviral treatment strategies for HIV-1 infection. AIDS 2001;15:1985-91.
31. O'Cleirigh C, Ironson G, Herbst J, Costa PT. Conscientiousness is related to disease progression (viral load and CD4 cell number) and adherence in patients living with HIV/AIDS. Manuscript in preparation, 2002.
32. Palella F, Delaney K, Moorman A, Loveless MO, Fuhrer J, Satten GA, Aschman DJ, Holmberg SD. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998;338:853-60.
33. Patterson DL, Swindells S, Mohr J, Brester M, Vergis EN, Squier C, Wagener MM, Singh N. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med 2000;133(1):21-30.
34. Perkins DO, Davidson EJ, Leserman J, Liao D, Evans DL. Personality disorder in patients infected with HIV: A controlled study with implications for clinical care. Am J Psychiatry 1994;150(2):298-9.
35. Piedmont RL, Weinstein HP. A psychometric evaluation of the new NEO PI-R facets scales for Agreeableness and Conscientiousness. J Pers Assess 1993;60:302-18.
36. Power C, Selnes O, Grim J, McArthur J. HIV Dementia Scale: A rapid screening test. J AIDS Hum Retroviruses 1995;8:273-8.
37. Samuels JF, Nestadt G, Romanoski AJ, Folstein MF, McHugh PR. DSM-III personality disorders in the community. Am J Psychiatry 1994;1055-62.
38. Sikkema KJ, Kochman A, DiFranceisco W, Bergholte J, Peterson M. Psychiatric co-morbidity in HIV secondary prevention. National HIV Prev. Conference, Medical College of Wisconsin, Milwaukee. Abstract No. 284, 1999.
39. Spitzer R, Williams J, Gibbon M, First M. Structured Clinical Interview for DSM-III-R: Nonpatient Version for HIV Studies (SCID-NP-HIV 6/1/88). New York (NY): Biometrics Research Department, New York Psychiatric Institute, 1988.
40. Yamakoa K, Shigehisa T, Ogoshi K, Haruyama K, Watanabe M, Hayashi F, Hayashi C. Health-related quality of life varies with personality types: A comparison among cancer patients, non-cancer patients and healthy individuals in a Japanese population. Qual Life Res 1998;7(6):535-44.